The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death
Benzinga
JULY 11, 2022
Perrigo Company plc's (NYSE: PRGO ) HRA Pharma has submitted its application to the FDA for the first-ever over-the-counter (OTC) birth control pill. The company has applied for an Rx-to-OTC switch for Opill, a progestin-only daily birth control pill (also referred to as a mini pill or non-estrogen pill).
Let's personalize your content